GM06935
Fibroblast from Skin, Unspecified
Description:
FANCONI ANEMIA COMPLEMENTATION GROUP UNDETERMINED
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Repair Defective and Chromosomal Instability Syndromes |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Simian Virus 40
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Race
|
White
|
Ethnicity
|
ARABIAN
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
27 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis. DNA fingerprinting and HLA DQ-alpha typing showed that this SV40 transformed fibroblast culture had the same pattern and genotype as GM02053, the untransformed fibroblast. |
|
Remarks |
Clinically affected; pancytopenia; brown patchy pigmentation on skin; untransformed fibroblasts are not sensitive to cell killing by mitomycin-C or diepoxybutane even at higher concentrations; modal number of chromosomes is 114, range is 106 to 122; structural aberrations & polyploidy; SV40 transformed GM02053. |
Ruppitsch W, Meisslitzer C, Weirich-Schwaiger H, Klocker H, Scheidereit C, Schweiger M, Hirsch-Kauffmann M, The role of oxygen metabolism for the pathological phenotype of Fanconi anemia. Hum Genet99:710-9 1997 |
PubMed ID: 9187662 |
|
Saito H, Grompe M, Neeley TL, Jakobs PM, Moses RE, Fanconi anemia cells have a normal gene structure for topoisomerase I. Hum Genet93:583-6 1994 |
PubMed ID: 8168839 |
|
Saito H, Moses RE, Immortalization of Werner syndrome and progeria fibroblasts Experimental cell research192:373-9 1991 |
PubMed ID: 1671011 |
Passage Frozen |
27 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
10% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|